Availability of Mental Telehealth Services Varies by Geography, Facility
By Lori Solomon HealthDay Reporter
WEDNESDAY, Feb. 7, 2024 -- Geographic and facility factors influence the availability of mental telehealth services, according to a study published online Feb. 2 in JAMA Health Forum.
Jonathan Cantor, Ph.D., from the RAND Corporation in Santa Monica, California, and colleagues quantified availability, wait times, and service features of telehealth for major depressive disorder, general anxiety disorder, and schizophrenia throughout the United States. The analysis included a secret shopper survey of 1,221 mental health treatment facilities (MHTFs) throughout all U.S. states except Hawaii from December 2022 to March 2023.
The researchers found that 87 percent of facilities were accepting new patients and 80 percent reported offering telehealth, with availability not differing by clinical condition. Among those offering telehealth services, 97 percent reported availability of counseling services, 77 percent medication management, and 69 percent diagnostic services. Telehealth was more likely to be offered at private for-profit (adjusted odds ratio, 1.75) and private nonprofit (adjusted odds ratio, 2.20) facilities. The median wait time for a first telehealth appointment was 14 days (range, four to 75 days).
"These findings suggest that there are significant differences in the availability of telehealth appointments by location of MHTFs across the United States, but few differences based on the client-caller’s demographic characteristics or mental health condition," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-08 00:15
Read more
- Once Again, Tuberculosis Becomes World's Top Infectious Disease Killer
- U.S. Infant Deaths Rose After Fall of Roe v. Wade
- CDC Says Some People May Need Extra Dose of COVID Vaccine
- Virtual Yoga Classes Aid Chronic Low Back Pain
- FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
- Parents or Ambulance: How a Child Reaches an ER Could Matter
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions